Kalevi Kairemo

4.1k total citations
164 papers, 2.6k citations indexed

About

Kalevi Kairemo is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kalevi Kairemo has authored 164 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Radiology, Nuclear Medicine and Imaging, 64 papers in Pulmonary and Respiratory Medicine and 36 papers in Oncology. Recurrent topics in Kalevi Kairemo's work include Radiopharmaceutical Chemistry and Applications (74 papers), Prostate Cancer Treatment and Research (37 papers) and Medical Imaging Techniques and Applications (34 papers). Kalevi Kairemo is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (74 papers), Prostate Cancer Treatment and Research (37 papers) and Medical Imaging Techniques and Applications (34 papers). Kalevi Kairemo collaborates with scholars based in Finland, United States and Germany. Kalevi Kairemo's co-authors include Finn Edler von Eyben, Timo Joensuu, Antti Jekunen, Oula Peñate Medina, Ying Zhu, Kaarina Partanen, Akseli Hemminki, Timo Kiljunen, Ernest K. J. Pauwels and Irene Virgolini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kalevi Kairemo

159 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kalevi Kairemo Finland 27 960 799 793 644 491 164 2.6k
Alan Alfieri United States 28 595 0.6× 523 0.7× 584 0.7× 816 1.3× 142 0.3× 66 2.6k
Hee‐Seung Bom South Korea 25 740 0.8× 441 0.6× 408 0.5× 526 0.8× 317 0.6× 126 2.6k
Nicholas H. A. Terry United States 28 450 0.5× 559 0.7× 647 0.8× 854 1.3× 206 0.4× 90 2.3k
Vikas Kundra United States 32 781 0.8× 805 1.0× 667 0.8× 1.9k 2.9× 168 0.3× 113 4.0k
Pierre Verrelle France 30 471 0.5× 1.1k 1.4× 946 1.2× 1.1k 1.7× 135 0.3× 137 3.3k
Pete Lollar United States 45 566 0.6× 328 0.4× 447 0.6× 1.1k 1.7× 634 1.3× 138 5.4k
William D. Bloomer United States 32 836 0.9× 543 0.7× 491 0.6× 658 1.0× 209 0.4× 142 3.2k
Denise S. O’Keefe United States 21 540 0.6× 786 1.0× 339 0.4× 691 1.1× 184 0.4× 29 1.7k
Regina Gandour‐Edwards United States 34 337 0.4× 918 1.1× 929 1.2× 1.1k 1.7× 220 0.4× 122 3.3k
Gordon W. Philpott United States 29 1.0k 1.1× 755 0.9× 998 1.3× 528 0.8× 260 0.5× 61 3.2k

Countries citing papers authored by Kalevi Kairemo

Since Specialization
Citations

This map shows the geographic impact of Kalevi Kairemo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalevi Kairemo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalevi Kairemo more than expected).

Fields of papers citing papers by Kalevi Kairemo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kalevi Kairemo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalevi Kairemo. The network helps show where Kalevi Kairemo may publish in the future.

Co-authorship network of co-authors of Kalevi Kairemo

This figure shows the co-authorship network connecting the top 25 collaborators of Kalevi Kairemo. A scholar is included among the top collaborators of Kalevi Kairemo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kalevi Kairemo. Kalevi Kairemo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hoffmann, Manuela A., Çiğdem Soydal, Irene Virgolini, et al.. (2025). Management Based on Pretreatment PSMA PET of Patients with Localized High-Risk Prostate Cancer Part 2: Prediction of Recurrence—A Systematic Review and Meta-Analysis. Cancers. 17(5). 841–841. 1 indexed citations
3.
Eyben, Finn Edler von, Kalevi Kairemo, & Daniel S. Kapp. (2024). Prostate-Specific Antigen as an Ultrasensitive Biomarker for Patients with Early Recurrent Prostate Cancer: How Low Shall We Go? A Systematic Review. Biomedicines. 12(4). 822–822.
4.
Kairemo, Kalevi, Mohamed A. Gouda, Hubert H. Chuang, Homer A. Macapinlac, & Vivek Subbiah. (2024). Deciphering Tumor Response: The Role of Fluoro-18-d-Glucose Uptake in Evaluating Targeted Therapies with Tyrosine Kinase Inhibitors. Journal of Clinical Medicine. 13(11). 3269–3269. 1 indexed citations
5.
Gouda, Mohamed A., Maria A. Zarzour, Ara A. Vaporciyan, et al.. (2023). Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma. Oncoscience. 10. 44–53. 1 indexed citations
6.
Lin, Mai, et al.. (2020). Prostate-Specific Membrane Antigen-Targeted Radiopharmaceuticals in Diagnosis and Therapy of Prostate Cancer: Current Status and Future Perspectives. Cancer Biotherapy and Radiopharmaceuticals. 36(3). 237–251. 7 indexed citations
7.
Zhu, Hanwen, Olga Will, Yahya Açil, et al.. (2020). Utilizing ICG Spectroscopical Properties for Real-Time Nanoparticle Release Quantification In vitro and In vivo in Imaging Setups. Current Pharmaceutical Design. 26(31). 3828–3833. 4 indexed citations
8.
Benezra, Miriam, et al.. (2020). Alpha-MSH Targeted Liposomal Nanoparticle for Imaging in Inflammatory Bowel Disease (IBD). Current Pharmaceutical Design. 26(31). 3840–3846. 11 indexed citations
9.
Subbiah, Vivek, Pete Anderson, Kalevi Kairemo, et al.. (2019). Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial. Clinical Cancer Research. 25(13). 3802–3810. 32 indexed citations
10.
Kairemo, Kalevi & Timo Joensuu. (2018). Lu-177-PSMA treatment for metastatic prostate cancer: case examples of major responses. Clinical and Translational Imaging. 6(3). 223–237. 7 indexed citations
11.
Eyben, Finn Edler von, Giandomenico Roviello, Timo Kiljunen, et al.. (2017). Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review. European Journal of Nuclear Medicine and Molecular Imaging. 45(3). 496–508. 136 indexed citations
12.
Kairemo, Kalevi, et al.. (2014). Preliminary Clinical Experience oftrans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PET/CT Imaging in Prostate Cancer Patients. BioMed Research International. 2014. 1–7. 41 indexed citations
13.
Kanerva, Anna, Petri Nokisalmi, Iulia Diaconu, et al.. (2013). Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus. Clinical Cancer Research. 19(10). 2734–2744. 144 indexed citations
14.
Pesonen, Sari, Iulia Diaconu, Lotta Kangasniemi, et al.. (2012). Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients. Cancer Research. 72(7). 1621–1631. 107 indexed citations
15.
Hakkarainen, Tanja, Maria Rajecki, Mirkka Sarparanta, et al.. (2009). Targeted Radiotherapy for Prostate Cancer with an Oncolytic Adenovirus Coding for Human Sodium Iodide Symporter. Clinical Cancer Research. 15(17). 5396–5403. 33 indexed citations
16.
Pauwels, Ernest K. J., Kim Bergström, Giuliano Mariani, & Kalevi Kairemo. (2009). Microdosing, Imaging Biomarkers and SPECT: A Multi-Sided Tripod to Accelerate Drug Development. Current Pharmaceutical Design. 15(9). 928–934. 11 indexed citations
17.
Jääskelä-Saari, Hilkka, Reidar Grénman, Hans Ramsay, et al.. (2005). Indium-111-Bleomycin Complex in Squamous Cell Cancer Xenograft Tumors of Nude Mice. Cancer Biotherapy and Radiopharmaceuticals. 20(4). 426–435. 4 indexed citations
18.
Kairemo, Kalevi, et al.. (1996). Modulation of antibody kinetics by the cell membrane active agent tween 80 in vivo.. PubMed. 16(6B). 3542–50. 3 indexed citations
19.
Kairemo, Kalevi, et al.. (1996). Double-Tracer Dosimetry of Organs in Assessment of Bone Marrow Involvement by Two Monoclonal Antibodies. Acta Oncologica. 35(3). 357–365. 2 indexed citations
20.
Kairemo, Kalevi, Hans Ramsay, Timo Paavonen, & S. Bondestam. (1996). Imaging and staging of head and neck cancer using a low pH in-111-bleomycin complex. European Journal of Cancer Part B Oral Oncology. 32(5). 311–321. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan Alfieri Breakdown of academic impact, for papers by Hee‐Seung Bom Breakdown of academic impact, for papers by Nicholas H. A. Terry Breakdown of academic impact, for papers by Vikas Kundra Breakdown of academic impact, for papers by Pierre Verrelle Breakdown of academic impact, for papers by Pete Lollar Breakdown of academic impact, for papers by William D. Bloomer Breakdown of academic impact, for papers by Denise S. O’Keefe Breakdown of academic impact, for papers by Regina Gandour‐Edwards Breakdown of academic impact, for papers by Gordon W. Philpott
Rankless by CCL
2026